| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- articolo scientifico (it)
- artigo científico (pt)
- bilimsel makale (tr)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научни чланак (sr)
- article scientifique (fr)
- artículu científicu espublizáu en 1995 (ast)
- наукова стаття, опублікована в січні 1995 (uk)
- مقالة علمية نشرت في يناير 1995 (ar)
- scientific article published on January 1995 (en)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| cites work
| |
| cites work
| - Additivity of prostaglandin F2 alpha-1-isopropyl ester to timolol in glaucoma patients
- Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey
- Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey.
- Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes
- The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes
- Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes
- The effect of adding prostaglandin F2 alpha-isopropylester to timolol in patients with open angle glaucoma
- PhXA34--a prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension
- PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers
- Maintained intraocular pressure reduction with once-a-day application of a new prostaglandin F2 alpha analogue (PhXA41). An in-hospital, placebo-controlled study
- Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimens
- Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study
- Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure
- Prostaglandin F2 alpha-1-isopropylester lowers intraocular pressure without decreasing aqueous humor flow
- Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension
- The effect of prostaglandin F2 alpha on trabecular outflow facility in cynomolgus monkeys
|
| author name string
| |
| author name string
| - Heijl A
- Söderström M
- Alm A
- Friström B
- Kjellgren D
- Stjerschantz J
- Widengård I
|
| rdfs:label
| - Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol (en)
- Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol (nl)
- Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol (ast)
|
| skos:prefLabel
| - Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol (en)
- Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol (nl)
- Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol (ast)
|
| name
| - Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol (en)
- Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol (nl)
- Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol (ast)
|
| title
| |
| title
| - Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| |
| ResearchGate publication ID
| |
| ResearchGate publication ID
| |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)